Rhythm Pharmaceuticals (RYTM) Revenue Growth (3y) (2024 - 2026)
Rhythm Pharmaceuticals (RYTM) Revenue Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | 79.44% |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | - |
| 10 | Rhythm Pharmaceuticals | 7.32 Bn | 6.98 Bn | 52.96 Mn | 73.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73.70% |
| Dec 31, 2025 | 108.88% |
| Sep 30, 2025 | 128.78% |
| Jun 30, 2025 | 74.90% |
| Mar 31, 2025 | 179.49% |
| Dec 31, 2024 | 184.48% |
| Sep 30, 2024 | 218.62% |
| Jun 30, 2024 | 373.45% |
| Mar 31, 2024 | 805.28% |